1 April 1993
8 December 1986
COMMERCIAL ITEM DESCRIPTION
DISOPYRAMIDE PHOSPHATE CAPSULES, USP
The General Services Administration has authorized the use of this Commercial Item Description.
Shall be Disopyramide Phosphate Capsules, USP.
Shall be in accordance with the requirements of the USP.
For Strength I, shall contain a quantity of Disopyramide Phosphate equivalent to 100 mg of Disopyramide Base per capsule, within the applicable assay limits.
For Strength II, shall contain a quantity of Disopyramide Phosphate equivalent to 150 mg of Disopyramide Base per capsule, within the applicable assay limits.
Each capsule shall be marked/embossed with a product identification code to identify the active ingredient(s), strength, and manufacturer. The materials used in marking/embossing the dosage forms shall be acceptable to the FDA. The actual code used for the product shall be left to the discretion of the supplier.
All ingredients entering into the manufacture of the capsules shall be of pharmaceutical grade.
Workmanship. The capsules shall be free from defects which detract from their appearance or impair its serviceability.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business